Unusual case of dasatinib-associated acute bilateral hyphemas leading to blindness in a patient with chronic myeloid leukaemia

Chronic myeloid leukaemia (CML) is a myeloproliferative disorder with an incidence of 1–2 cases per 100 000 adults per year.(1) Since the International Randomized Study of Interferon and STI571 trial (IRIS trial) in 2003, treatment with tyrosine kinase inhibitors (TKIs) has become the standard of ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Case Rep
Autori principali: Sharma, Sandhya, Garg, Natasha, Ghiuzeli, Cristina M
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2018
Soggetti:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119381/
https://ncbi.nlm.nih.gov/pubmed/30150345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-225705
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi